2018 annual financial data
Travere Therapeutics 2018 Operating margin
Direct answer
Operating margin was -48.73%.
Operating income was -80,040,000 USD and net income was -102,678,000 USD.
Operating cash flow was -24,958,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 164,246,000 USD
- Operating income
- -80,040,000 USD
- Net income
- -102,678,000 USD
- Operating cash flow
- -24,958,000 USD